@article{05f282c146824c179826734ee46f082f,
title = "An IL-9–pulmonary macrophage axis defines the allergic lung inflammatory environment",
abstract = "Despite IL-9 functioning as a pleiotropic cytokine in mucosal environments, the IL-9–responsive cell repertoire is still not well defined. Here, we found that IL-9 mediates proallergic activities in the lungs by targeting lung macrophages. IL-9 inhibits alveolar macrophage expansion and promotes recruitment of monocytes that develop into CD11c+ and CD11c− interstitial macrophage populations. Interstitial macrophages were required for IL-9–dependent allergic responses. Mechanistically, IL-9 affected the function of lung macrophages by inducing Arg1 activity. Compared with Arg1-deficient lung macrophages, Arg1-expressing macrophages expressed greater amounts of CCL5. Adoptive transfer of Arg1+ lung macrophages but not Arg1− lung macrophages promoted allergic inflammation that Il9r−/− mice were protected against. In parallel, the elevated expression of IL-9, IL-9R, Arg1, and CCL5 was correlated with disease in patients with asthma. Thus, our study uncovers an IL-9/macrophage/ Arg1 axis as a potential therapeutic target for allergic airway inflammation.",
author = "Yongyao Fu and Jocelyn Wang and Baohua Zhou and Abigail Pajulas and Hongyu Gao and Baskar Ramdas and Byunghee Koh and Ulrich, {Benjamin J.} and Shuangshuang Yang and Reuben Kapur and Renauld, {Jean Christophe} and Sophie Paczesny and Yunlong Liu and Tighe, {Robert M.} and Paula Licona-Lim{\'o}n and Flavell, {Richard A.} and Shogo Takatsuka and Daisuke Kitamura and Tepper, {Robert S.} and Jie Sun and Kaplan, {Mark H.}",
note = "Funding Information: This work was supported by Public Health Service grants from the National Institutes of Health (R01 AI129241 to M.H.K.). B.Z. was supported by Public Health Service grants from the National Institutes of Health (R01 AI085046). B.J.U. was supported by National Institutes of Health grants T32 AI060519 and F30 HL147515. A.P. was supported by National Institutes of Health grant T32 AI060519. J.S. was supported by Public Health Service grants from the National Institutes of Health (AG069264 and AI147394). The Indiana University Melvin and Bren Simon Comprehensive Cancer Center Flow Cytometry Resource Facility were supported, in part, by NIH, National Cancer Institute (NCI) grant P30 CA082709 and National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant U54 DK106846. The Flow Cytometry Resource Facility was supported, in part, by NIH instrumentation grant 1S10D012270. Support provided by the Herman B Wells Center for Pediatric Research was, in part, from the Riley Children{\textquoteright}s Foundation. Publisher Copyright: Copyright {\textcopyright} 2022 The Authors, some rights reserved;",
year = "2022",
month = feb,
doi = "10.1126/sciimmunol.abi9768",
language = "English (US)",
volume = "7",
journal = "Science Immunology",
issn = "2470-9468",
publisher = "American Association for the Advancement of Science",
number = "68",
}